Capricor Therapeutics (CAPR) Profit After Tax: 2011-2025
Historic Profit After Tax for Capricor Therapeutics (CAPR) over the last 13 years, with Sep 2025 value amounting to -$24.6 million.
- Capricor Therapeutics' Profit After Tax fell 95.68% to -$24.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$68.6 million, marking a year-over-year decrease of 101.20%. This contributed to the annual value of -$40.5 million for FY2024, which is 81.57% down from last year.
- According to the latest figures from Q3 2025, Capricor Therapeutics' Profit After Tax is -$24.6 million, which was down 0.73% from -$24.4 million recorded in Q2 2025.
- In the past 5 years, Capricor Therapeutics' Profit After Tax ranged from a high of -$762,089 in Q4 2023 and a low of -$24.6 million during Q3 2025.
- In the last 3 years, Capricor Therapeutics' Profit After Tax had a median value of -$8.8 million in 2023 and averaged -$11.2 million.
- Per our database at Business Quant, Capricor Therapeutics' Profit After Tax skyrocketed by 90.13% in 2023 and then plummeted by 833.83% in 2024.
- Quarterly analysis of 5 years shows Capricor Therapeutics' Profit After Tax stood at -$6.2 million in 2021, then fell by 24.72% to -$7.7 million in 2022, then soared by 90.13% to -$762,089 in 2023, then slumped by 833.83% to -$7.1 million in 2024, then slumped by 95.68% to -$24.6 million in 2025.
- Its Profit After Tax was -$24.6 million in Q3 2025, compared to -$24.4 million in Q2 2025 and -$7.1 million in Q4 2024.